Ischemic Time Impacts Biological Integrity of Phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK Signaling Networks

被引:0
作者
Holzer, Timothy R. [1 ]
Fulford, Angie D. [1 ]
Arkins, Austin M. [1 ]
Grondin, Janet M. [1 ]
Mundy, Christopher W. [1 ]
Nasir, Aejaz [1 ]
Schade, Andrew E. [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
Ischemia; immunohistochemistry; xenografts; phospho-proteins; pre-analytical variables; biopsy; PHOSPHOINOSITIDE; 3-KINASE; LUNG-CANCER; MUTATIONS; TISSUE; PHOSPHORYLATION; GEFITINIB; STABILITY; ONCOGENE; FIXATION; PATHWAY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Post-translational modifications of proteins, such as phosphorylation, are labile events dynamically regulated by opposing kinase and phosphatase activities. Preanalytical factors, such as ischemic time before fixation, affect these activities and can have a significant impact on the ability to elucidate signaling pathways in tissue. Immunohistochemical analysis of phosphorylated proteins involved in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks was performed in human cell line xenografts from lung, brain, ovary, and prostate tumors. In order to replicate real-world practices, the tissues were subjected to ischemic times of 0 (baseline), 1, 4, and 24 hours before fixation in formalin. Two key concepts emerge from this analysis: (1) the stability of different phospho-epitopes within a given tumor type is variable (e.g. phospho-PRAS40 is more labile than phospho-S6 ribosomal protein) and (2) the stability of a given phospho-epitope (e.g. phospho-MAPKAPK2) varies significantly across different tumor types. These results highlight the importance of proper tissue acquisition and rapid fixation to preserve the biological integrity of signal transduction pathways that may guide therapeutic decision making.
引用
收藏
页码:2073 / 2081
页数:9
相关论文
共 32 条
  • [1] Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation
    Aboudola, Samer
    Murugesan, Guruanthan
    Szpurka, Hadrian
    Ramsingh, Giri
    Zhao, Xiaoxian
    Prescott, Nichole
    Tubbs, Raymond R.
    Maciejewski, Jaroslaw P.
    Hsi, Eric D.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (02) : 233 - 239
  • [2] Stability of phosphoprotein as a biological marker of tumor signaling
    Baker, AF
    Dragovich, T
    Ihle, NT
    Williams, R
    Fenoglio-Preiser, C
    Powis, G
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4338 - 4340
  • [3] Cancer biomarker validation: Standards and process - Roles for the National Institute of Standards and Technology (NIST)
    Barker, PE
    [J]. EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 : 142 - 150
  • [4] Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts
    Birie, Diana C.
    Hedley, David W.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (10) : 2494 - 2502
  • [5] Quantitative In Situ Detection of Phosphoproteins in Fixed Tissues Using Quantum Dot Technology
    Bodo, Juraj
    Durkin, Lisa
    Hsi, Eric D.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2009, 57 (07) : 701 - 708
  • [6] Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis
    Brader, S
    Eccles, SA
    [J]. TUMORI JOURNAL, 2004, 90 (01): : 2 - 8
  • [7] p38 MAPK in development and cancer
    Bradham, Cynthia
    McClay, David R.
    [J]. CELL CYCLE, 2006, 5 (08) : 824 - 828
  • [8] Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry
    Torlakovic, Emina Emilia
    Riddell, Robert
    Banerjee, Diponkar
    El-Zimaity, Hala
    Pilavdzic, Dragana
    Dawe, Peter
    Magliocco, Anthony
    Barnes, Penny
    Berendt, Richard
    Cook, Donald
    Gilks, Blake
    Williams, Gaynor
    Perez-Ordonez, Bayardo
    Wehrli, Bret
    Swanson, Paul E.
    Otis, Christopher N.
    Nielsen, Soren
    Vyberg, Mogens
    Butany, Jagdish
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (03) : 354 - 365
  • [9] MAP kinases
    Chen, Z
    Gibson, TB
    Robinson, F
    Silvestro, L
    Pearson, G
    Xu, BE
    Wright, A
    Vanderbilt, C
    Cobb, MH
    [J]. CHEMICAL REVIEWS, 2001, 101 (08) : 2449 - 2476
  • [10] The impact of histochemistry - a historical perspective
    Coleman, R
    [J]. ACTA HISTOCHEMICA, 2000, 102 (01) : 5 - 14